SCHEMBL7206800

SCHEMBL7206800

Cc1ccc(S(=O)(=O)NCCCN(CCCN(CCCN(CCCNS(=O)(=O)c2ccc(C)cc2)S(=O)(=O)c2ccc(C)cc2)Cc2ccccc2)S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.54
CA9 Q16790 2/20 0.54
CA2 P00918 1/20 0.54
CNR2 P34972 6/20 0.54
TMEM97 Q5BJF2 1/20 0.54
SIGMAR1 Q99720 1/20 0.54
OPRK1 P41145 3/20 0.53
ALOX15 P16050 1/20 0.53
TAS2R14 Q9NYV8 1/20 0.51
OPRM1 P35372 1/20 0.51
ALDH1A1 P00352 2/20 0.50
RAB9A P51151 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
BACE1 P56817 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
ATM Q13315 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7201652 0.97 CNR2 (0.53) CA12CA9CA2CNR2TMEM97
SCHEMBL7203881 0.92 CA12 (0.63) CA12CA9CA2TMEM97SIGMAR1
SCHEMBL3905679 0.85 CA12 (0.72) CA12CA9CA2ALOX15ALDH1A1
SCHEMBL7199478 0.84 CNR2 (0.60) CNR2TAS2R14
SCHEMBL3969287 0.84 OPRK1 (0.63) CA12CA9CA2TMEM97SIGMAR1
SCHEMBL472226 0.84 CA12 (0.70) CA12CA9CA2ALOX15ALDH1A1
SCHEMBL7203889 0.84 CA12 (0.70) CA12CA9CA2ALOX15ALDH1A1
SCHEMBL3898192 0.84 CA12 (0.70) CA12CA9CA2ALOX15ALDH1A1
SCHEMBL7204962 0.83 CNR2 (0.59) CNR2TAS2R14
SCHEMBL7206806 0.83 CNR2 (0.61) CNR2TAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605645-B2 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action RIKEN (JP) 2003-08-12 US disclosed
US-20020067472-A1 Linear polyamine compounds and polyamine anticancer agents IWATA MASAAKI (JP) 2002-06-06 US disclosed
US-6319956-B1 N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. RIKEN (JP) 2001-11-20 US disclosed